SCHEMBL25922973

SCHEMBL25922973

CBc1ccc(OCCBr)cc1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
GPR84 Q9NQS5 1/20 0.34
PTGES O14684 1/20 0.34
ALOX5 P09917 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.31
AR P10275 2/20 0.31
MAOB P27338 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30
APP P05067 1/20 0.30
CHRNB2 P17787 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25919979 0.76 AR (0.39) NPC1MAPTRAB9ASMN1; SMN2THRA
SCHEMBL25314684 0.74 ALOX5AP (0.40) NPC1MAPTRAB9ASMN1; SMN2THRA
SCHEMBL25317633 0.71 THRA (0.47) MAPTRAB9ATHRATHRBPTGES
SCHEMBL25317121 0.71 DRD2 (0.40) NPC1RAB9A
SCHEMBL25317341 0.71 THRA (0.37) NPC1MAPTRAB9ASMN1; SMN2THRA
SCHEMBL25316793 0.70 PDIA6 (0.36) NPC1MAPTRAB9ASMN1; SMN2THRA
SCHEMBL4332998 0.68 LTA4H (0.50) PPARAMAOBCHRNB2CHRNB4CHRNA3
SCHEMBL7010616 0.68 ALDH1A1 (0.44) NPC1MAPTRAB9ASMN1; SMN2THRB
SCHEMBL14434929 0.68 IDO1 (0.42) AR
SCHEMBL19649433 0.67 PDK2 (0.46) MAPTTHRATHRBGPR84PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed